FDA Breakthrough Designation Standards Revealed (Kind Of)
Executive Summary
Janet Woodcock says agency still cannot detail specific criteria for the popular incentive, but data on breakthrough requests show common characteristics.
You may also be interested in...
Competitive Generic Therapy Designations Growing Despite Lack Of Guidance
US FDA developing document describing program operations, but that has not stopped sponsors from requesting and receiving the breakthrough-like designation.
Competitive Generic Therapy Designations Growing Despite Lack Of Guidance
US FDA developing document describing program operations, but that has not stopped sponsors from requesting and receiving the breakthrough-like designation.
Breakthrough Therapies: Maintain The Statistical Rigor, Industry Says
Janssen statistician says FDA should ensure breakthrough sponsors follow the rules just like traditional applicants, although agency statistician experience with designees has been limited.